+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Second day to subscribe to Medplus Health Services’ IPO; GMP at ₹250 per share

Dec 15, 2021, 07:00 IST
Medplus
  • Pharmacy retail chain MedPlus Health Services has been subscribed 1.46 times on the first day of the IPO bidding process.
  • The company is looking to raise ₹1,639 crore through the IPO with a price band of ₹780 to ₹796 per share.
  • Shares of the company are demanding a premium of ₹250 in the grey market, which has come down from ₹300 earlier.
Advertisement
Today, December 15, is the second day to subscribe to Hyderabad-based pharmacy retail chain MedPlus Health Services’ initial public offering (IPO), which has already been fully subscribed on the first day itself.

The IPO of the pharmacy retail firm has been subscribed 146% so far. The company is looking to raise ₹1,398 crore through the IPO out of which a fresh issue of ₹600 crore worth of shares and an offer for sale of shares worth ₹798.29 crore by selling shareholders.
Investor category Subscription
Qualified institutional buyers0.09 times
Non-institutional investors 0.50 times
Retail2.64 times
Overall1.46 times

Shares of the company are demanding a premium of ₹250 in the grey market, which has come down from ₹300 earlier.

If you’re looking to invest in the IPO, read what analysts are talking about the company. Analysts are bullish on the company as it sees several growth opportunities in the pharmacy retailing space.

Analysts at ICICIdirect say that MedPlus with its clustered store presence is well suited to leverage on an omni-channel platform (online and offline) with a hyper local delivery model. “We assign SUBSCRIBE rating given its unique model and decent valuation,” said the brokerage firm.

Advertisement

The company is India's second-largest pharmacy retailer in terms of the number of stores and revenue. It sells a wide range of products, including pharmaceutical and wellness products -- medicines, vitamins, medical devices and test kits, and fast-moving consumer goods -- home and personal care products, toiletries, baby care products, soaps and detergents, and sanitisers.
Flourish chart

SEE ALSO: Supriya Lifescience IPO to open on December 16: Check out important details related to the IPO

Anand Rathi Wealth makes a modest listing at 9% premium on exchanges
You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article